KOCAA
TXMD icon

Knights of Columbus Asset Advisors’s TherapeuticsMD TXMD Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,302
Closed -$271K – 328
2021
Q3 		$271K Sell
7,302
-6,800
-48% -$302K 0.02% 266
2021
Q2 		$839K Hold
14,102
– – 0.08% 230
2021
Q1 		$945K Hold
14,102
– – 0.09% 246
2020
Q4 		$853K Hold
14,102
– – 0.09% 255
2020
Q3 		$1.11M Hold
14,102
– – 0.14% 229
2020
Q2 		$881K Hold
14,102
– – 0.11% 256
2020
Q1 		$747K Hold
14,102
– – 0.09% 280
2019
Q4 		$1.71M Buy
+14,102
New +$2.03M 0.15% 242

Other funds holding TXMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Knights of Columbus Asset Advisors's TXMD Position: Q4 2021 in Review

Knights of Columbus Asset Advisors sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 7,302 shares — an estimated $271K sold.

Knights of Columbus Asset Advisors first reported a position in TXMD in Q4 2019 and held it in 8 quarters. The position peaked at $1.71M in Q4 2019. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.

  • Knights of Columbus Asset Advisors reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 7,302 TherapeuticsMD shares in Q4 2021, an estimated $271K.
  • Knights of Columbus Asset Advisors first reported a position in TherapeuticsMD in Q4 2019 and held it in 8 quarters.
  • Knights of Columbus Asset Advisors's TherapeuticsMD position peaked at $1.71M in Q4 2019.
  • 131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.

Based on Knights of Columbus Asset Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.